JLABS
JLABS is Johnson & Johnson's global life science incubator network, providing early-stage health technology and biotech startups with capital-efficient lab space, J&J expert access, and entrepreneurial programs across eight physical and virtual sites in major life science hubs worldwide.
- Company typePrivate
- Founded2012
- HeadquartersSan Diego, United States
- Headcount5,001–10,000
- GTM typeB2B
- OfferingServices
What JLABS does
JLABS (legal entity: Johnson & Johnson Innovation – JLABS) is the global life science incubator network of Johnson & Johnson (NYSE: JNJ), founded in 2012 and headquartered in San Diego, California. It operates eight physical and virtual sites situated in premier life science hubs — San Diego, San Francisco (South San Francisco), Cambridge/Boston (JLABS @ LabCentral), Shanghai, Singapore, Seoul (JLABS Korea Phase 1), and an EMEA regional hub — and serves early-stage life science and health technology startups. Its core offering is capital-efficient lab space bundled with wraparound services: infrastructure and lab equipment, access to Johnson & Johnson expertise and investor networks, entrepreneurial programming, and visibility within the healthcare industry.
The platform is delivered through three primary routes: (1) Physical Residency at any of the eight sites for startups that need wet-lab infrastructure and in-person proximity to the J&J network; (2) Virtual Membership, which grants remote access to J&J experts, research institutions, and partnerships without requiring physical presence; and (3) QuickFire Challenges, a competitive innovation program awarding grant funding, JLABS residency, and J&J expert engagement to winners of themed healthcare problem-solving calls. Supporting infrastructure includes the JLABS Navigator (an interactive directory of residents, members, and alumni) and JPALS (a Johnson & Johnson expert-engagement platform).
JLABS's business model is a recurring subscription/residency fee structure. Specific pricing is not publicly disclosed. The unit's strategic value to J&J is not measured on standalone P&L but on deal flow: 380+ portfolio companies have closed deals, strategic partnerships, or QuickFire Challenge awards with Johnson & Johnson, and 60+ have reached public markets via IPOs or reverse mergers. JLABS is wholly owned by J&J and has no independent fundraising; operationally it functions as a deal-sourcing, venture-validation, and startup-incubation division within J&J's broader innovation and venture capital apparatus (which includes JJDC).
JLABS firmographics
Firmographics- Name
- JLABS
- Legal name
- Johnson & Johnson Innovation – JLABS
- Website
- https://jlabs.jnjinnovation.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- JLABS is Johnson & Johnson's global life science incubator network, providing early-stage health technology and biotech startups with capital-efficient lab space, J&J expert access, and entrepreneurial programs across eight physical and virtual sites in major life science hubs worldwide.
- Ownership category
- akta.pro rank
JLABS industry classification
Industry- Product category
- Life Science Incubator Services
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Laboratory Apparatus & Furniture (3821), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers) (HLAGAIAG)
Keywords
Where JLABS is headquartered
LocationHeadquarters
- HQ city
- San Diego
- HQ country
- United States
- HQ region
- North America
Offices7 records
Markets served
JLABS business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Infrastructure, Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Residency and Membership Programs: JLABS generates value by providing capital-efficient lab space, resources, and access to Johnson & Johnson expertise and network connections to early-stage life science and health technology companies. Revenue is derived from residency fees for physical lab space and virtual membership subscriptions, though specific pricing is not publicly disclosed.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
JLABS product offering
Product offeringCore offering
JLABS operates a global life science incubator network providing early-stage life science and health technology startups with capital-efficient laboratory space, entrepreneurial programming, expertise access, and industry connections. The network spans 8 physical and virtual sites in major life science hubs, offering physical residency, virtual membership, QuickFire Challenges, and wraparound services such as JPALS expert access and JLABS Navigator company discovery.
Product overview
JLABS is a unified global incubator platform operated by Johnson & Johnson, providing life science and health technology startups with wraparound services including physical and virtual residency programs, expertise access through JPALS, interactive company discovery via JLABS Navigator, and innovation challenges. The platform offers capital-efficient lab space at 8 strategic global locations, entrepreneurial programming, investor connections, and visibility within the healthcare industry ecosystem.
Differentiator
Problem solved
Functional benefit
Products and services
- JLABS Physical Residency
- JLABS Virtual Membership
Quantifiable outcome
- 60+ companies have gone public through IPOs or reverse mergers
- +1 more outcomes
Companies that use JLABS
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles1 record
JLABS technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
JLABS partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Johnson & Johnson Innovation – JLABS (parent entity)coreJohnson & Johnson Innovation – JLABS is partnered with OsseoLabs and the Faculty of Medicine Ramathibodi Hospital, Mahidol University as a supporter of the Osscentric: Medical Technology Innovation Sandbox initiative. The partnership aims to position Thai-developed medical innovations for entry into the global MedTech market through the Yothi Medical Innovation District (YMID).
- TILSNAminorTILSNA is a supporting partner in the Osscentric initiative alongside Johnson & Johnson Innovation – JLABS, focused on accelerating medical technology development in Thailand.
- LabCentralcoreJLABS @ LabCentral is a co-located incubator arrangement in Cambridge, Massachusetts, combining JLABS' resources and Johnson & Johnson network with LabCentral's established startup ecosystem and infrastructure.
Scale indicators3 records
Recent moves5 records
Expansion highlights5 records
JLABS competitors and assessment
Company assessmentDirect peers
- BioGenerator: St. Louis-based life science startup creator and investor that builds and funds biotech companies. Comparable to JLABS in life science startup creation mission, though more focused on the St. Louis/Midwest ecosystem.
- Alexandria LaunchLabs: Alexandria Real Estate's startup incubator platform providing turnkey lab and office space to life science ventures across multiple US hubs. Directly comparable to JLABS in target customer, real-estate-plus-services business model, and presence in major biotech clusters.
- IndieBio: Biotech-focused accelerator (operating in SF and NY) that combines capital, lab infrastructure, and mentorship for early-stage biology startups. Directly comparable to JLABS's mission of accelerating life science ventures, though IndieBio also deploys its own venture capital.
- Cambridge Innovation Center (CIC): Operator of large shared innovation and lab facilities across multiple US and global cities for startups, including life sciences tenants. Comparable to JLABS in physical incubator model and shared infrastructure offering, though broader across industries.
- LabCentral: Boston/Cambridge-based life science incubator providing co-working lab space and services to biotech startups. Directly comparable to JLABS in target customer (early-stage life science founders) and offering (furnished lab + community), and is in fact a co-location partner via 'JLABS @ LabCentral'.
- MBC BioLabs: Bay Area life science incubator offering capital-efficient lab space to early-stage biotech startups. Directly comparable to JLABS in target market, business model (furnished lab + membership), and geographic focus on a major US life science hub.
Regional players
- MaRS Discovery District: Toronto-based innovation hub offering lab and office space, mentorship, and programming for health and life science ventures. Comparable to JLABS's incubator-plus-resources model, though primarily serving the Canadian market.
Emerging players
- Petri: Early-stage biotech accelerator providing capital, mentorship, and lab access to first-time founders. Comparable to JLABS's life science startup mission at the earliest stage, with more emphasis on first-time and underrepresented founders.
Broad incumbents
- Bayer Co.Lab: Bayer's global life science incubator network with sites in the US, Europe, China, and Brazil. Directly comparable to JLABS in pharma-backed life science incubation model, though Bayer's broader portfolio and consumer health focus give it different scope.
- Roche Accelerator: Roche's startup incubation and partnership program supporting diagnostics and digital health ventures globally. Comparable to JLABS in pharma-corporate-affiliated incubator model, though focused more narrowly on Roche's therapeutic and diagnostic priorities.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
JLABS social profiles
Digital presenceJLABS financial estimates
Financial estimateRevenue estimate
Valuation estimate
JLABS leadership team
Management profileNumber of profiles
Profiles1 record
JLABS subsidiaries and ownership
Company hierarchySubsidiaries2 records
JLABS funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
JLABS M&A and investment
M&A and investmentM&A
Investments10 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about JLABS
What does JLABS do?
JLABS operates a global life science incubator network providing early-stage life science and health technology startups with capital-efficient laboratory space, entrepreneurial programming, expertise access, and industry connections. The network spans 8 physical and virtual sites in major life science hubs, offering physical residency, virtual membership, QuickFire Challenges, and wraparound services such as JPALS expert access and JLABS Navigator company discovery.
Is JLABS a public or private company?
JLABS is a private company. It is classified as corporate owned and is currently operating.
When was JLABS founded?
JLABS was founded in 2012. It employs 5,001 to 10,000 people.
Where is JLABS based?
JLABS is headquartered in San Diego, United States, in the North America region.
How does JLABS make money?
One revenue line is on record: residency and Membership Programs.
Who are JLABS's main competitors?
Direct peers on record are BioGenerator, Alexandria LaunchLabs, IndieBio, Cambridge Innovation Center (CIC), LabCentral and MBC BioLabs. MaRS Discovery District is listed as a regional player. Petri is listed as an emerging player. Broad incumbents are Bayer Co.Lab and Roche Accelerator.
Does JLABS have an API?
No public API is recorded for JLABS.
What industry is JLABS in?
JLABS's product category is Life Science Incubator Services. Its primary akta.pro industry code is HLAGAIAG, Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers). Its NAICS code is 54171 and its SIC code is 3821.